PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatocellular carcinoma |
| Symptom | |chronic hepatitis |
| Sentences | 118 |
| PubMedID- 25650331 | Purpose: to evaluate whether a hepatic fibrosis index (hfi), quantified on the basis of hepatic contour abnormality, is a risk factor for the development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c. |
| PubMedID- 21859997 | Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis b and c. |
| PubMedID- 24148650 | Outcomes following liver resection and clinical pathologic characteristics of hepatocellular carcinoma occurring in patients with chronic hepatitis b and minimally fibrotic liver. |
| PubMedID- 21129375 | Background & aims: interferon reportedly decreases the incidence of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c. |
| PubMedID- 24485003 | Thus, the present study was designed to investigate the protective effect of s-adenosylmethionine (same) on hiri, especially for patients with hepatocellular carcinoma (hcc) associated with chronic hepatitis b virus (hbv) infection and cirrhosis. |
| PubMedID- 21286340 | Liver stiffness measurement in the risk assessment of hepatocellular carcinoma for patients with chronic hepatitis. |
| PubMedID- 26012225 | This study elucidated the role of insulin resistance assessed by the homeostasis model (homa-ir) in development of hepatocellular carcinoma associated with chronic hepatitis c infection. |
| PubMedID- 24703510 | Impact of epidermal growth factor single-nucleotide polymorphism on recurrence of hepatocellular carcinoma after hepatectomy in patients with chronic hepatitis c virus infection. |
| PubMedID- 24248733 | Microrna-196a-2 polymorphisms and hepatocellular carcinoma in patients with chronic hepatitis b. |
| PubMedID- 25133046 | Prevention of hepatocellular carcinoma in patients with chronic hepatitis b. |
| PubMedID- 23099187 | Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis c: a prospective, multicenter study. |
| PubMedID- 20095888 | Risk of hepatocellular carcinoma in patients with chronic hepatitis b virus infection. |
| PubMedID- 24662676 | Given the role of hepatocellular cd81 in hcv infection and the association of chronic hepatitis c with hepatocellular carcinoma (hcc) there is a growing interest in studying the function of cd81 in hepatocytes. |
| PubMedID- 21160979 | Effect of antiviral treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis b. |
| PubMedID- 22957763 | A high incidence of tumor recurrence and metastasis has been reported in hepatocellular carcinoma (hcc) patients with chronic hepatitis b virus (hbv) infection. |
| PubMedID- 23090836 | Role of leptin receptor (lepr) gene polymorphisms and haplotypes in susceptibility to hepatocellular carcinoma in subjects with chronic hepatitis b virus infection. |
| PubMedID- 20458764 | Aim: to elucidate the role of insulin resistance (ir) and serum adiponectin level in hepatocellular carcinoma (hcc) associated with chronic hepatitis c. |
| PubMedID- 25873850 | The present case was a young man, a known case of chronic hepatitis b with multiple recurrent hepatocellular carcinoma, who presented with clinical sepsis and jaundice. |
| PubMedID- 25921128 | Cyp2c19 genotype could be a predictive factor for aggressive manifestations of hepatocellular carcinoma related with chronic hepatitis b infection in thailand. |
| PubMedID- 23202460 | Glycyrrhizin, for instance, a component of licorice roots extract, has been shown to prevent the development of hepatocellular carcinoma in patients with chronic hepatitis . |
| PubMedID- 24772876 | Concurrent development of non-hodgkin lymphoma and hepatocellular carcinoma in patient with chronic hepatitis c. |
| PubMedID- 22899800 | A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis c after sustained response to pegylated interferon and ribavirin combination therapy. |
| PubMedID- 22659345 | Polymorphisms of dna repair genes in korean hepatocellular carcinoma patients with chronic hepatitis b: possible implications on survival. |
| PubMedID- 20616578 | Impact of peginterferon maintenance therapy on the risk of developing hepatocellular carcinoma in patients with chronic hepatitis c virus. |
| PubMedID- 26508201 | Characteristics and prognosis of hepatocellular carcinoma detected in patients with chronic hepatitis c after the eradication of hepatitis c virus: a multicenter study from japan. |
| PubMedID- 25569223 | Blood gene signature for early hepatocellular carcinoma detection in patients with chronic hepatitis b. |
| PubMedID- 24930484 | Here, we assessed the prognostic performance of lsps in predicting the development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis b (chb). |
| PubMedID- 23945731 | Random-effects inverse variance meta-analysis of antiviral therapy treatment effects on hepatocellular carcinoma in patients with chronic hepatitis b and cirrhosis, subgroups according to trial design. |
| PubMedID- 24223115 | The progression of hepatic fibrosis is an important predictive factor for the development of lc and hepatocellular carcinoma not only in patients with chronic hepatitis c, but also in those with nash 4. |
| PubMedID- 20166172 | Incidence of hepatocellular carcinoma in patients with chronic hepatitis b virus infection who have normal alanine aminotransferase values. |
| PubMedID- 23258096 | Effect of response to interferon-alpha therapy on the occurrence of hepatocellular carcinoma in patients with chronic hepatitis b. |
| PubMedID- 23225825 | The present study was approved by our ethics committee and written informed consent was obtained from all 48 male patients scheduled for liver transplantation for cirrhosis or hepatocellular carcinoma with chronic hepatitis b virus infection. |
| PubMedID- 22427959 | Helicobacter hepaticus (h. hepaticus), another enteric pathogen known to induce spontaneous, chronic colitis in certain susceptible mouse strains, is also associated with active chronic hepatitis and development of hepatocellular carcinoma in both inbred and knockout strains of mice , , . |
| PubMedID- 23701091 | Objective: the objective of our study was to describe the cross-sectional imaging appearance of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c virus (hcv) infection in the absence of advanced fibrosis and cirrhosis. |
| PubMedID- 22966320 | Development of hepatocellular carcinoma in patients with chronic hepatitis c more than 10 years after sustained virological response to interferon therapy. |
| PubMedID- 24995497 | Aspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis b virus infection. |
| PubMedID- 24128413 | Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis b. |
| PubMedID- 22174720 | In the same study, a 10-year prospective case-control study found that chronic hepatic schistosomiasis conveyed roughly the same risk for development of hepatocellular carcinoma as other causes of chronic hepatitis such as hcv, although note was made in this study that there were a high number of cases that showed coinfection by hcv and s. japonicum, possibly biasing the data. |
| PubMedID- 23237253 | The article reviewed here reports on the prognostic role of liver stiffness as measured by transient elastography and other noninvasive methods in the prediction of clinical decompensation and hepatocellular carcinoma in patients with chronic hepatitis b. |
| PubMedID- 24704525 | Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis b: a nationwide cohort study. |
| PubMedID- 21619694 | Similar findings have been reported in previous studies, including hepatocellular carcinoma associated with chronic hepatitis c, gastric carcinoma, and sporadic endometrial carcinoma , suggesting an interaction of mdm2 snp309, infectious factor, and hormone factor. |
| PubMedID- 21461077 | Background/aims: despite great progress, antiviral treatment for chronic hepatitis c in patients with prior hepatocellular carcinoma (hcc) has been rarely investigated. |
| PubMedID- 21253791 | Overall, these data suggest that chemoprevention of hepatocellular carcinoma in patients with chronic hepatitis c is an achievable objective. |
| PubMedID- 23602201 | High tumor necrosis factor-alpha/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 22419005 | Does antiviral therapy reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 21170963 | Obesity and metabolic syndrome are recognized risk factors for development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c (chc). |
| PubMedID- 24918150 | Antiviral therapy is not enough to prevent hepatocellular carcinoma development in patients with chronic hepatitis b. |
| PubMedID- 21520203 | Occult hepatitis b virus infection and hepatocellular carcinoma development in patients with chronic hepatitis c. |
| PubMedID- 22212935 | Prevention of hepatocellular carcinoma in patients with chronic hepatitis b virus infection. |
| PubMedID- 20924214 | Background/aims: whether alcohol intake increases the risk of hepatocellular carcinoma (hcc) in patients with chronic hepatitis b virus (hbv) infection remains controversial. |